Back to Search
Start Over
Reboxetine versus other antidepressive agents for depression
- Publication Year :
- 2018
- Publisher :
- John Wiley & Sons, Ltd, 2018.
-
Abstract
- This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: 1) To determine the efficacy of reboxetine in comparison with other antidepressive agents in alleviating the acute symptoms of depression. 2) To investigate acceptability of treatment with reboxetine in comparison with other antidepressive agents. 3) To investigate the adverse effects of reboxetine in comparison with other antidepressive agents.
- Subjects :
- Medicine General & Introductory Medical Sciences
amfebutamone
antidepressant agent
citalopram
duloxetine
fluoxetine
fluvoxamine
Hypericum extract
maprotiline
milnacipran
mirtazapine
paroxetine
reboxetine
sertraline
tricyclic antidepressant agent
venlafaxine
bioassay
clinical assessment
Cochrane Library
comparative study
cost of illness
data extraction
diagnostic and statistical manual of mental disorders
drug efficacy
drug tolerability
Hamilton scale
Hypericum
major depression
mental health service
mental patient
monotherapy
outcome assessment
patient selection
practice guideline
quality of life
risk assessment
sensitivity analysis
systematic review
treatment duration
treatment outcome
unspecified side effect
Pharmacology (medical)
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....8420f1cdb853c1971efb4d7f371764e1